Founded

Address

BiPar Sciences Inc
00000
United States

Open map

KANDO id: 130256

Corporate information

Official name
BiPar Sciences, Inc.
Registration country

Company type

Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients.

Funding rounds

Series C


( )

Profile Country
Asset Management Co Venture Capital (Asset Management Ventures), (AMV) Early-stage venture capital firm investing in digital health.
Canaan Partners Venture capital firm with a focus on early stage technology and healthcare companies
Domain Associates LLC Venture capital firm focused on life sciences companies.
Polytechnos Venture-Partners GmbH European venture capital firm focusing on privately held early stage companies, predominantly in Europe
Quantum Technology Partners
Vulcan Inc (Vulcan Capital)

Series B


( )

Profile Country
Asset Management Co Venture Capital (Asset Management Ventures), (AMV) Early-stage venture capital firm investing in digital health.
Canaan Partners Venture capital firm with a focus on early stage technology and healthcare companies
Domain Associates LLC Venture capital firm focused on life sciences companies.
Polytechnos Venture-Partners GmbH European venture capital firm focusing on privately held early stage companies, predominantly in Europe
Quantum Technology Partners
Vulcan Inc (Vulcan Capital)

Debt


( )


Series A


( )

Profile Country
Asset Management Co Venture Capital (Asset Management Ventures), (AMV) Early-stage venture capital firm investing in digital health.
Canaan Partners Venture capital firm with a focus on early stage technology and healthcare companies
Polytechnos Venture-Partners GmbH European venture capital firm focusing on privately held early stage companies, predominantly in Europe
Quantum Technology Partners
Vulcan Inc (Vulcan Capital)


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials